2008 Keynotes
Andrew C. von Eschenbach, M.D Commissioner of the U.S. Food and Drug Administration
A nationally recognized urologic surgeon and oncologist, Dr. von Eschenbach’s distinguished career as a key leader in the fight against cancer spans nearly three decades. Prior to being appointed to lead the NCI in January 2002, Dr. von Eschenbach served as Executive Vice President and Chief Academic Officer of the University of Texas M.D. Anderson Cancer Center in Houston. Read more
Sidney Taurel Chairman and CEO, Eli Lilly and Company
Sidney Taurel is chairman and chief executive officer for Eli Lilly and Company. He became chief executive officer in July 1998 and chairman of the board of directors on January 1, 1999. Born a Spanish citizen in Casablanca, Morocco, Taurel became an American citizen in November 1995. Read more
Nicholas J. Valeriani Vice President, Office of Strategy & Growth, Johnson & Johnson
Nicholas J. Valeriani is Worldwide Chairman, Cardiovascular Devices and Diagnostics, and a member of the Executive Committee of Johnson & Johnson. He is responsible for the Cordis Corporation, LifeScan, Inc., and Ortho-Clinical Diagnostics, Inc., businesses and is a member of the Medical Devices & Diagnostics Group Operating Committee. Read more
Jim Yong Kim, M.D., Ph.D. Director, François-Xavier Bagnoud Center for Health and Human Rights Harvard School of Public Health
Dr. Kim has 20 years of experience in improving health in developing countries. He is a
founding trustee and the former executive director of Partners In Health, a not-for-profit
organization that supports a range of health programs in poor communities in Haiti, Peru,
Russia, Rwanda, Lesotho, and the US. Read more
Michael Porter, Ph.D.
Bishop William Lawrence University Professor
Harvard Business School
Michael E. Porter is the Bishop William Lawrence University Professor at Harvard Business School. A leading authority on competitive strategy and the competitiveness of nations and regions, Professor Porter’s work is recognized in governments, corporations, non-profits, and academic circles across the globe. Read more
|